Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 5, 2012-06 ,pp. : 526-542

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

By Van Essen Martijn   Krenning Eric P.   De Jong Marion   Valkema Roelf   Kwekkeboom Dik J.  

Acta Oncologica, Vol. 46, Iss. 6, 2007-01 ,pp. : 723-734

Informa Healthcare

Access to resources Recommend Favorite

Experimental Antitumour Activity of S 16020-2 in a Panel of Human Tumours

By Kraus-Berthier L.   Guilbaud N.   Jan M.   Saint-Dizier D.   Rouillon M.H.   Burbridge M.F.   Pierre A.   Atassi G.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1881-1887

Elsevier

Access to resources Recommend Favorite

Somatostatin analogs for the treatment of neuroendocrine tumors

By Culler Michael   Öberg Kjell   Arnold Rudolf   Krenning Eric   Sevilla Isabel   Díaz José  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients

By Dhar S.   Gullbo J.   Csoka K.   Eriksson E.   Nilsson K.   Nickel P.   Larsson R.   Nygren P.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 803-809

Elsevier

Access to resources Recommend Favorite